New diabetes clinical trial: Dapagliflozin in Living-Donor Kidney Transplant Recipients
Published on: 2026-04-29T04:00:00Z
Conditions: Kidney Transplant; Kidney Transplant Failure
Interventions: Drug: Dapagliflozin (10mg Tab); Other: Standard of Care
Sponsors: University of Guadalajara; Instituto Mexicano del Seguro Social
Active, not recruiting
https://ift.tt/sT4JDXu
Conditions: Kidney Transplant; Kidney Transplant Failure
Interventions: Drug: Dapagliflozin (10mg Tab); Other: Standard of Care
Sponsors: University of Guadalajara; Instituto Mexicano del Seguro Social
Active, not recruiting
https://ift.tt/sT4JDXu
Comments
Post a Comment